ID   I 4
AC   CVCL_C379
SY   I4; Israel number 4; TE04; TE-04; TECHe002-A
DR   GEO; GSM856735
DR   GEO; GSM862726
DR   hPSCreg; TECHe002-A
DR   ISCR; 122
DR   NIHhESC; NIHhESC-13-0205
DR   SKIP; SKIP001860
DR   WiCell; te04
DR   Wikidata; Q54897063
RX   PubMed=16919167;
RX   PubMed=23117585;
RX   PubMed=28445466;
WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=42
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0205.
CC   HLA typing: A*03:24; B*35:02,38; C*04,12; DQB1*01,06; DRB1*13,13; DRB3*01 (PubMed=16919167).
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=te04
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14 (PubMed=16919167)
ST   D13S317: 12,14,15 (WiCell=te04)
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 20
//
RX   PubMed=16919167; DOI=10.1186/1741-7007-4-28;
RA   Josephson R., Sykes G.R., Liu Y., Ording C.J., Xu W.-N., Zeng X.-M.,
RA   Shin S., Loring J.F., Maitra A., Rao M.S., Auerbach J.M.;
RT   "A molecular scheme for improved characterization of human embryonic
RT   stem cell lines.";
RL   BMC Biol. 4:28.1-28.13(2006).
//
RX   PubMed=23117585; DOI=10.1016/j.scr.2012.09.002;
RA   Mallon B.S., Chenoweth J.G., Johnson K.R., Hamilton R.S., Tesar P.J.,
RA   Yavatkar A.S., Tyson L.J., Park K., Chen K.G., Fann Y.C., McKay R.D.G.;
RT   "StemCellDB: the human pluripotent stem cell database at the National
RT   Institutes of Health.";
RL   Stem Cell Res. 10:57-66(2013).
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//